Onesource Specialty Pharma Q3 Results
- BSE: 544292
- NSE: ONESOURCE
- ISIN: INE013P01021
- Sector: Biotechnology & Drugs
BSE
1,787.45
-50.05 (-2.72%)
-50.05 (-2.72%)Volume10.07 K
Updated: Fri 5 Jun, 2026 | 15:29:27
NSE
1,789.70-48.20 (-2.62%)
-48.20 (-2.62%)Volume1.51 L
Updated: Fri 5 Jun, 2026 | 15:40:15
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Onesource Specialty Pharma Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 349.75 | 330.33 | 3.14% | 419.96 | -16.72% |
| Depreciation/ Amortization | 69.64 | 68.28 | -0.27% | 68.77 | 1.27% |
| Operating Income | -59.40 | 3.72 | 0.00% | -27.40 | 116.81% |
| Net Income | -88.70 | -42.08 | 0.00% | -68.85 | 28.83% |
| Other Operating Expenses Total | 114.46 | 78.34 | 23.13% | 91.79 | 24.70% |
| Net Income Before Taxes | -93.01 | -37.45 | 0.00% | -66.50 | 39.86% |
| Total Revenue | 290.34 | 334.05 | -22.73% | 392.56 | -26.04% |
| Selling/ General/ Admin Expenses Total | 64.19 | 53.98 | 2.18% | 57.35 | 11.93% |
| Diluted Normalized EPS | -7.34 | -3.54 | 0.00% | -0.32 | 2181.67% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.